Retrospective CT/MRI Texture Analysis of Rapidly Progressive Hepatocellular Carcinoma
Open Access
- 20 September 2020
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 10 (3), 136
- https://doi.org/10.3390/jpm10030136
Abstract
Rapidly progressive hepatocellular carcinoma (RPHCC) is a subset of hepatocellular carcinoma that demonstrates accelerated growth, and the radiographic features of RPHCC versus non-RPHCC have not been determined. The purpose of this retrospective study was to use baseline radiologic features and texture analysis for the accurate detection of RPHCC and subsequent improvement of clinical outcomes. We conducted a qualitative visual analysis and texture analysis, which selectively extracted and enhanced imaging features of different sizes and intensity variation including mean gray-level intensity (mean), standard deviation (SD), entropy, mean of the positive pixels (MPP), skewness, and kurtosis at each spatial scaling factor (SSF) value of RPHCC and non-RPHCC tumors in a computed tomography (CT) cohort of n = 11 RPHCC and n = 11 non-RPHCC and a magnetic resonance imaging (MRI) cohort of n = 13 RPHCC and n = 10 non-RPHCC. There was a statistically significant difference across visual CT irregular margins p = 0.030 and CT texture features in SSF between RPHCC and non-RPHCC for SSF-6, coarse-texture scale, mean p = 0.023, SD p = 0.053, MPP p = 0.023. A composite score of mean SSF-6 binarized + SD SSF-6 binarized + MPP SSF-6 binarized + irregular margins was significantly different between RPHCC and non-RPHCC (p = 0.001). A composite score ≥3 identified RPHCC with a sensitivity of 81.8% and specificity of 81.8% (AUC = 0.884, p = 0.002). CT coarse-texture-scale features in combination with visually detected irregular margins were able to statistically differentiate between RPHCC and non-RPHCC. By developing an image-based, non-invasive diagnostic criterion, we created a composite score that can identify RPHCC patients at their early stages when they are still eligible for transplantation, improving the clinical course of patient care.This publication has 28 references indexed in Scilit:
- Milan criteria and its expansions in liver transplantation for hepatocellular carcinomaHepatoBiliary Surgery and Nutrition, 2016
- Intention to treat outcome of T1 hepatocellular carcinoma with the “wait and not ablate” approach until meeting T2 criteria for liver transplant listingLiver Transplantation, 2015
- Characteristics of Hypovascular versus Hypervascular Well-Differentiated Hepatocellular Carcinoma Smaller Than 2 cm - Focus on Tumor Size, Markers and Imaging DetectabilityDigestive Diseases, 2015
- Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver diseaseClinical and Molecular Hepatology, 2015
- CT texture analysis using the filtration-histogram method: what do the measurements mean?Cancer Imaging, 2013
- Enhancement patterns of hepatocellular carcinomas on multiphasic multidetector row CT: comparison with pathological differentiationThe British Journal of Radiology, 2012
- Hepatocellular CarcinomaThe New England Journal of Medicine, 2011
- MRI findings of rapidly progressive hepatocellular carcinomaMagnetic Resonance Imaging, 2010
- Surgical treatment of hepatocellular carcinoma: expert consensus statementHPB, 2010
- Hepatocellular Carcinoma with a Pseudocapsule on Gadolinium-enhanced MR Images: Correlation with Histopathologic FindingsRadiology, 2009